Pancreatic Cancer Research

ResearcherWashington University in St. LouisActive in the last 2 years

Chet W. Hammill

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9749-0824; OpenAlex author ID A5076989398. Sources: OpenAlex.

Their work

Papers
12 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
1
Collaborators
55
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 2 papers · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 2 papers · 2022: 1 paper · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers

Papers 12

  1. Association of irreversible electroporation treatment with overall survival in Stage III pancreatic ductal adenocarcinoma: DIRECT registry results. Co-author DOI 10.1093/oncolo/oyag416↗
  2. Irreversible electroporation associated with improved overall survival vs standard of care for stage 3 pancreatic ductal adenocarcinoma Co-author DOI 10.64898/2026.05.19.26353144↗
  3. Patient expectations about the oncologic benefit of pancreatectomy for pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.hpb.2025.07.017↗
  4. Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected pancreatic cancer: A multi-institutional ana… Co-author DOI 10.1002/jso.27798↗
  5. MR-Guided Radiation Therapy With Concurrent Gemcitabine/Nab-Paclitaxel Chemotherapy in Inoperable Pancreatic Cancer: A TITE-CRM Phase I Trial. Co-author DOI 10.1016/j.ijrobp.2022.07.015↗
  6. Racial Disparity in Pathologic Response following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: A Multi-Institutional Analysis from the Central Pancr… Co-author DOI 10.1245/s10434-022-12741-4↗
  7. Intraoperative Pancreatic Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in the Era of Neoadjuvant Therapy: A Multi-instit… Co-author DOI 10.1245/s10434-022-11804-w↗
  8. Screening for Pancreatic Ductal Adenocarcinoma: Are We Asking the Impossible? Last author DOI 10.1158/1940-6207.capr-20-0426↗
  9. Screening for Pancreatic Ductal Adenocarcinoma: Are We Asking the Impossible?—Response First author DOI 10.1158/1940-6207.capr-21-0257↗
  10. Total pancreatectomy for pancreatic ductal adenocarcinoma: review of the National Cancer Data Base. Co-author DOI 10.1016/j.hpb.2015.07.009↗
  11. A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pa… Co-author DOI 10.1186/s40425-016-0149-6↗
  12. Neoadjuvant radiation therapy and its impact on complications after pancreaticoduodenectomy for pancreatic cancer: analysis of the American College of Surgeons… Co-author DOI 10.1111/hpb.12141↗

Closest collaborators

The 25 strongest of 55 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Robert C.G. Martin · 4 shared papers, 2022–2026 · strength 0.87
  2. Daniel Erik Abbott · 4 shared papers, 2022–2025 · strength 0.64
  3. Nipun B. Merchant · 4 shared papers, 2022–2025 · strength 0.64
  4. Shishir Kumar Maithel · 4 shared papers, 2022–2025 · strength 0.64
  5. Govindarajan Narayanan · 2 shared papers, 2026 · strength 0.54
  6. Patricio Marcelo Polanco · 2 shared papers, 2026 · strength 0.54
  7. Sean Patrick Cleary · 2 shared papers, 2026 · strength 0.54
  8. Michael D. Kluger · 2 shared papers, 2026 · strength 0.54
  9. Carlos H.F. Chan · 2 shared papers, 2026 · strength 0.54
  10. Rebekah Ruth White · 2 shared papers, 2026 · strength 0.54
  11. Alexander A. Parikh · 3 shared papers, 2023–2025 · strength 0.50
  12. Rebecca Anne Snyder · 3 shared papers, 2023–2025 · strength 0.50
  13. Katharine E. Caldwell · 2 shared papers, 2021 · strength 0.50
  14. Syed Ameen Ahmad · 3 shared papers, 2022–2025 · strength 0.47
  15. Jashodeep Datta · 3 shared papers, 2022–2025 · strength 0.47
  16. Gregory C. Wilson · 3 shared papers, 2022–2024 · strength 0.44
  17. David A. Kooby · 3 shared papers, 2022–2024 · strength 0.44
  18. Hong Joo Kim · 3 shared papers, 2022–2024 · strength 0.44
  19. Ifeanyichukwu Chinedu Ogobuiro · 2 shared papers, 2023–2024 · strength 0.31
  20. David A. Iannitti · 1 shared paper, 2026 · strength 0.27
  21. Benjamin A. Y. Cher · 1 shared paper, 2025 · strength 0.19
  22. Sharon Marie Weber · 1 shared paper, 2025 · strength 0.19
  23. Sameer H. Patel · 1 shared paper, 2025 · strength 0.19
  24. Mihir Maheshkumar Shah · 1 shared paper, 2025 · strength 0.19
  25. Charles Raben Scoggins · 1 shared paper, 2025 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.